These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2917537)

  • 1. Acute renal failure after endoscopic injection sclerotherapy: a report of two cases.
    Yamaga H; Hashizume M; Kitano S; Higashi H; Yoshino I; Sugimachi K
    Endoscopy; 1989 Jan; 21(1):43. PubMed ID: 2917537
    [No Abstract]   [Full Text] [Related]  

  • 2. Haptoglobin prevents renal dysfunction associated with intravariceal infusion of ethanolamine oleate.
    Miyoshi H; Ohshiba S; Matsumoto A; Takada K; Umegaki E; Hirata I
    Am J Gastroenterol; 1991 Nov; 86(11):1638-41. PubMed ID: 1951242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The prophylactic effect of haptoglobin administration on renal disfunction in endoscopic injection sclerotherapy].
    Miyoshi H; Oshiba S; Matsumoto A; Hayashi K; Tei H
    Nihon Shokakibyo Gakkai Zasshi; 1989 Feb; 86(2):280. PubMed ID: 2754835
    [No Abstract]   [Full Text] [Related]  

  • 4. Squamous cell carcinoma after endoscopic injection sclerotherapy for esophageal varices.
    Kokudo N; Sanjo K; Umekita N; Harihara Y; Tada Y; Idezuki Y
    Am J Gastroenterol; 1990 Jul; 85(7):861-4. PubMed ID: 2196786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Endoscopic injection sclerotherapy using a balloon-attached endoscope].
    Yazaki Y; Namiki M
    Nihon Rinsho; 1990 Apr; 48(4):689-93. PubMed ID: 2366353
    [No Abstract]   [Full Text] [Related]  

  • 6. Disseminated intravascular coagulation (DIC) after endoscopic injection sclerotherapy with ethanolamine oleate.
    Bellary SV; Isaacs P
    Endoscopy; 1990 May; 22(3):151. PubMed ID: 2357939
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pulmonary circulatory disturbance following endoscopic injection sclerotherapy].
    Uchibori S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Jul; 31(7):833-9. PubMed ID: 8366622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haptoglobin to protect against renal damage from ethanolamine oleate sclerosant.
    Hashizume M; Kitano S; Yamaga H; Sugimachi K
    Lancet; 1988 Aug; 2(8606):340-1. PubMed ID: 2899760
    [No Abstract]   [Full Text] [Related]  

  • 9. Albumin inhibits hemolysis of erythrocytes induced by ethanolamine oleate during endoscopic injection sclerotherapy.
    Ohta M; Hashizume M; Ueno K; Tanoue K; Sugimachi K
    Hepatogastroenterology; 1993 Feb; 40(1):65-8. PubMed ID: 8462932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of elective endoscopic sclerotherapy of hemorrhage from esophageal varices. 2-year follow-up].
    Cabriada J; Orive V; Alzate LF; Arenas JI
    Rev Esp Enferm Apar Dig; 1988 Oct; 74(4 Pt 2):429-34. PubMed ID: 3265215
    [No Abstract]   [Full Text] [Related]  

  • 11. Anaphylactic reaction to ethanolamine oleate injection in sclerotherapy of esophageal varices.
    Bordas JM; Feu F; Vilella A; Rodés J
    Endoscopy; 1989 Jan; 21(1):50. PubMed ID: 2917540
    [No Abstract]   [Full Text] [Related]  

  • 12. [38 cases of sclerotherapy of esophageal varices].
    Sigiyama K; Li ZL
    Zhonghua Nei Ke Za Zhi; 1985 May; 24(5):263-5, 317. PubMed ID: 3876916
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative effects of 5% ethanolamine oleate versus 5% ethanolamine oleate plus 1% polidocanol for sclerosing esophageal varices.
    Kitano S; Wada H; Tanoue K; Hashizume M; Koyanagi N; Sugimachi K
    Hepatogastroenterology; 1992 Dec; 39(6):546-8. PubMed ID: 1483669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric bleeding after endoscopic injection sclerotherapy for esophageal varices may be fatal.
    Higashi H; Kitano S; Hashizume M; Yamaga H; Wada H; Sugimachi K
    Int Surg; 1991; 76(4):214-7. PubMed ID: 1778718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term risk factors for bleeding after first course of endoscopic injection sclerotherapy: a univariate and multivariate analysis.
    Kokawa H; Shijo H; Kubara K; Nakaoka K; Toriya H; Shirai Z; Okazaki M
    Am J Gastroenterol; 1993 Aug; 88(8):1206-11. PubMed ID: 8393274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological findings in the esophagus after endoscopic sclerotherapy for variceal bleeding.
    Pushpanathan C; Idikio H
    Am J Gastroenterol; 1986 Jan; 81(1):9-13. PubMed ID: 3484607
    [No Abstract]   [Full Text] [Related]  

  • 17. Thoracic manifestations after esophageal variceal sclerotherapy.
    Wynchank S; Terblanche J; Bornman PC; Krige J
    Mayo Clin Proc; 1992 May; 67(5):501-2. PubMed ID: 1405779
    [No Abstract]   [Full Text] [Related]  

  • 18. [Endoscopic sclerotherapy of esophageal varices in pediatric patients].
    Salvatierra A; Granella L; Guevara ML; Barrios M; García MI; Salvatierra L
    G E N; 1992; 46(1):1-3. PubMed ID: 1305111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ethanolamine oleate as a sclerosing solution in the therapy of esophageal varices].
    Tsutsumi M; Takada A
    Nihon Rinsho; 1990 Apr; 48(4):713-7. PubMed ID: 2366357
    [No Abstract]   [Full Text] [Related]  

  • 20. [Endoscopic ligation and sclerotherapy in the treatment of esophageal varices].
    Pontone P; Pietropaolo V; Bogliolo G; Poschmann AH; Malgioglio AM
    G Chir; 1997 Oct; 18(10):715-8. PubMed ID: 9479993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.